Quick Answer
Neuronetics, Inc. reported R&D Expense of $6.58 million for fiscal year 2025.
Neuronetics, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $6.58M | -48.4% |
| 2024 | $12.77M | +34.2% |
| 2023 | $9.52M | +1.9% |
| 2022 | $9.34M | +17.8% |
| 2021 | $7.92M | -13.9% |
| 2020 | $9.20M | -33.1% |
| 2019 | $13.75M | +67.0% |
| 2018 | $8.23M | +3.7% |
| 2017 | $7.94M | -3.5% |
| 2016 | $8.22M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.50M | -37.7% | -16.4% |
| June 30, 2025 | $1.80M | -19.6% | +11.3% |
| March 31, 2025 | $1.62M | -31.2% | -33.1% |
| September 30, 2024 | $2.42M | +12.1% | +8.1% |
| June 30, 2024 | $2.23M | -5.5% | -4.9% |
| March 31, 2024 | $2.35M | -15.8% | +9.0% |
| September 30, 2023 | $2.15M | -8.2% | -8.8% |
| June 30, 2023 | $2.36M | +15.6% | -15.3% |
- Neuronetics, Inc. showed a decrease of -48.4% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Neuronetics, Inc.’s r&d expense has declined by 19.9% (from $8.22 million to $6.58 million).
- The most recent figure is from Neuronetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: